Ph / fax: 044-532-7765; PO Box 2404, Knysna, 6570. E-MAIL: pharmapact@hotmail.com or gaia.research@pixie.co.za

-CONTENTS-

Ph / fax: 044-532-7765; PO Box 2404, Knysna, 6570. E-MAIL: pharmapact@hotmail.com or gaia.research@pixie.co.za

Website: https://www.angelfire.com/biz/pharmapact E-mail: pharmapact@hotmail.com

GENOCIDE AND ETHNOPIRACY

Significantly subsection (5) moreover, specifically states that "Discrimination on one or more grounds listed in subsection (3) is unfair, unless it is established that the discrimination is fair". The onus is uniquely on the party wishing to discriminate, and hence to enforce compliance, the regulatory authority would have to, at their initiative, convince the Constitutional Court that the discrimination in these circumstances is fair, which is clearly impossible, given the facts presented hereunder. We note that recent MCCy /MRA propaganda statements indicate that the authorities are determined to avoid this dilemma by creating false divisional categories by strategically differentiating products to be regulated via the defining concept of "market", via the restrictive misapplication of the WHO criteria of "bulk", "finished" or "labelled" products, so as to attempt to exempt medicines used by African traditional healers and vendors from the SAMMDRA regulations, apparently due to a lack of heart or will to deal with this traditional medicine toxicity crisis.

Regarding "efficacy and safety" aspects, it is imperative to evaluate the relative risk from traditional African herbs and substances, since some 75% of the African population are estimated to use traditional substances, usually in combinations. According to the electronic database established by Noristan Laboratories, now with TramedF , of the 350 plant extracts assayed, some 79 % showed definite pharmacological activity, and 12 % definite toxic effects. (Hughson L, Pharmaceutical & Cosmetic Review, Jul / Aug 1995) How can these now ideologically escape the claimed need for urgent appropriate scheduling or safety regulations?

Professors Folb and Schlebusch, past chairman and registrar of the MCCy respectively, opinioned internationally a decade ago that "the issues of traditional medicines need to be addressed" (Folb P et al, J Clin Pharmacol 1988: 28), yet apparently a moratorium exists iro traditional medicines, in spite of Folb again writing, under the heading "Traditional drugs and indigenised pharmaceuticals", that "some give rise to serious adverse reactions, and others contain chemicals that have long term effects such as carcinogenicity and hepatoxicity." (Folb P, SA Jour Sci, Vol. 85. 1989 Aug) Why no urgent action here?

Whilst there is little difference between an African medicinal and the exotics, all of which except for the former are currently the target of such vicious regulatory fervour by the regulatory authorities, the only difference we have identified, is that the latter have had their problematically toxic items excluded from international commerce for fear of litigation, whereas this process has not occurred with the indigenous substances, but for very few items. With current budget constraints, we cannot conceive of bureaucratic systems receiving the disproportionately high priority afforded it for relatively safe products, when an urgent traditional medicines Toxics List and educational programme are the only practical ways to truly act in the consumer's interest and save several thousand lives each year, not to mention untold suffering.

Whilst researching an earlier report, we assumed that the morbidity and mortality incidence for South Africans using indigenous medicines would be minuscule, but we were stunned to uncover the shocking scientifically recorded and published clinical observation that "in South Africa, the major cause of death (from acute poisoning) among black South Africans are traditional medicines."!!!!! To reassure the reader that this was not a typographical error, the editor, a Clinical Professor of Medical Toxicology, added in brackets "(about 50 % of deaths)". (Ellenhorn's Medical Toxicity: Diagnosis and Treatment of Human Poisoning, Williams & Wilkins, 2^nd. Edn.1997) That this situation could have escaped the authorities and has not received swift remedial action, is not only unacceptable, it is clearly criminal.

Dr. P.H. Joubert, M.D., author of the internationally published article referenced in the above-mentioned textbook has, as Professor with the Dept. of Pharmacology & Therapeutics at the Medical University of South Africa (Medunsa)f been responsible for most of the epidemiological work in the shamefully neglected field of local indigenised medical toxicology. In spite of Joubert (and others) attempting for almost three decades to draw attention to this serious problem, practically nothing has been done to address this highly suspect apartheid oversight. Who needs a Third Force, when muti-medicine and a MCCy blind- eye to the problems, known to them for decades, will suffice as a silent tool for racist population control?

Joubert's successors and the medical press have played down this problem, eg. Dr. D.H Brand is mentioned in an article referring to follow-up work at Medunsaf , 1987-1993, but both the title of the article, "Accidental poisonings rare in herbals" and the theme, contrary to the facts, suggested a small percentage of overdose or poisoning from traditional medicine, whereas Dr Brand’s research had actually determined that "while only a small number of plant species were involved, these resulted in high mortality". (Medical Chronicle, Nov / Dec 1993); Brand also reported that "toxicity levels of Urginea sanguinea and some Drimia species are currently being investigated at Medunsaf , following the observation of toxic symptoms in patients who had taken herbal medicines". (Brand pers comm with Anne Hutchings); Dr E Osuch, Joubert’s current successor, in a recent thesis, confirmed that "The same traditional medicines (24 different plants) tended to recur as causes of hospital admissions…responsible for more than half of all acute poisoning deaths". (Thesis Summary)

Noteworthy is that this work continues at Medunsaf [Department of Pharmacology and Therapeutics], but now in determining the toxicity of traditional medicines in the "scientific marketplace". (S Afr J Sci 1997 Nov-Dec; 93(11/12)); The current department head, Prof W.J. du Plooy plays down the Medunsaf statistics by deliberately interpreting them in the most meaninglessly favourable light, in an effort to trivialise the problem. (pers comm 16 Feb 1998, & "Analysing the Epidemiology of Traditional Medicine Poisoning", delivered at the Complementary Health Care Summit, 25 August 1998, and advertised as "Determine how your organisation can capitalise from this unique opportunity in the market". Entrance fee: R2000+ per day for the 3-day event).

Urgent telephonic and e-mail requests made a year ago for specific research documents lodged in Du Plooy’s Dept at Medunsaf , to focus priority attention on this unacknowledged problem, have gone 90% unheeded. Du Plooy in his August presentation volunteers a grand total of one additional botanical name: Boophane disticha. Significantly, Du Plooy is a member of the NRC§ and a MRC¨ funding recipient for "Traditional medicines as part of the national drug policy" and " Toxicology of traditional medicines", so neither he nor the authorities can claim ignorance or obscure research. Paradoxically, du Plooy hypocritically concludes: "The public should be protected against compounds that have harmful properties. How? It is impossible for medicines." Even more hypocritically: "AT LEAST THE PUBLIC SHOULD BE WARNED! ie awareness."

THE ESTIMATED MORTALITY BURDEN FROM TRADITIONAL AFRICAN MEDICINES

What then are the facts? "Information on cause of death among adults in sub-Saharan Africa is essentially non-existent." (Kaufman J, et al Bull World Health Organisation, 1997; 75(5)), yet we can definitely confirm that a phenomenal problem exists, beyond the worst-case scenario expectations of most scientists and policy-makers. The author of this report estimates that annually several thousand deaths from traditional African medicines occur, far in excess of those dying of AIDS and significantly Dr M Stewart, Department of Chemical Pathology, SA Institute for Medical Research, concurs with this assessment, having recently determined "70 traditonal African medicine deaths in 8 months at Coronation Hospital, Johannesburg, and this just the few that made it to the hospital alive, only to die there, not to mention those who were/are extremely close to death." (pers comm, 31 March, 1999) It is significant that the major poisoning symptoms and causes of death from traditional African medicines closely mirror the major symptoms and causes of death (besides infectious) among the black population: diarrhoea, fetal distress, hypoglycaemia, renal / hepatic failure, respiratory distress, and cardiac failure.

"Information on cause of death among adults in sub-Saharan Africa is essentially non-existent, mostly extrapolations and outright guesses. Non-communicable diseases account for a significant portion, yet the empirical bases for public health policies and interventions are essentially absent." (Kaufman J, et al, Bull World Health Organisation, 1997, 75(5)); "Data on mortality and morbidity in South Africa are inadequate. The absence of a comprehensive national health information system, poses problems for an analysis of mortality." (White Paper on Population Policy, RSA, March 1998); "Estimating specific causes of death in South Africa is difficult, the last detailed information being almost a decade old, with no chance of an update, since the law was changed at that time to exclude the necessity of recording the details of the actual cause of death. The data collection system makes no provision for gathering the type of data needed to determine how many deaths might be attributable to traditional medicines. The overall figures must all be considered to be vast underestimates. Not all deaths in rural areas are registered and many are in the ill-defined category where it was not specified on the certificate." (pers comm. Dr Debbie Bradshaw, Centre for Epidemiological Research in Southern Africa, MRC¨ , 6 April 1999); "There is an urgent requirement for development of diagnostic methods in order to reduce the number of (cases, and) cases in which the death certificate refers only to the final pathology and not the causative agent." (Stewart M et al, Ther Drug Monit, 1998, Oct, 20(5))

The crude death rate in South Africa is 8.9 per 1 000 (1995 United Nations estimates, & RSA Stats in Brief, Aug 1996; 9.4/1000 according to DoH), meaning that approximately 400,000 of 40 million South African’s die each year. In the RSA 20% of all deaths are of unknown causes, (according to Stats South Africa: 13.71 ill-defined (15.2, DoH), 4.24 undetermined, and 1.61 other external). (Bradshaw D, Estimated Cause of Death Profiles SA, Based on 1990 Data, CERSA, MRC, 1991); Deaths from traditional African medicines could constitute a large portion of this 80,000 and it is not unrealistic to assume that traditional medicine poisoning deaths are responsible for at least 10% of the 80,000 annual deaths from unnatural causes, (excluding homicide, violence, accidents and self-inflicted), ie 8,000 traditional medicine mortalities would be conservative, confidently doubled to 15,000 and taking into account a percentage of deaths attributed to natural causes such as cardiac failure, 5000 additional of which may be traditional medicine induced, 20,000 is a conservative estimate for annual preventable deaths from traditional medicine.

Prof Pieter Joubert, ex Medunsaf , whose work is widely respected, published and cited internationally, has determined that "in developing countries, besides infectious conditions, acute poisonings with pesticides, paraffin (kerosene) and traditional medicines are the main causes of morbidity, whilst acute poisonings with traditional medicines is the main cause of mortality." (Joubert P, Mathibe L, Acute poisoning in developing countries, Adverse Drug React Acute Poisoning Rev 1989;8(3)); This assessment accurately pertains to local circumstances where "amongst black South Africans, the poisoning category is the second in order of importance in the five main causes of death (second only to contagious and parasitic diseases), whereas it is only the third and fourth category amongst the other groups." (Van Rensburg H, Mans A, Profiles of Disease and Health Care in South Africa, R&H Academica, 1982) This is confirmed by the 1990 MRC CERSA 91 data.

In a subsequent project covering 1981-1982 at Ga-Rankuwa Hospital, Pretoria, Joubert determined that "whilst 18 % of all acute poisonings were due to traditional medicines, most (86.58 %) of all deaths from acute poisoning were as a result of poisoning with traditional medicines" and concluded that (First World) "toxicology services, primarily geared towards the management of cases of drug poisoning, are inappropriate to the needs of developing communities." (Joubert P, Sebata B, "The role of prospective epidemiology in the establishment of a toxicology service for a developing community." S Afr Med J 1982 Nov 27; 62(23))

In a continuing project covering 1981-1985, also at Ga-Rankuwa Hospital, Joubert once again determined that "the main poisoning causes were paraffin (59 %), but with low mortality (2.1 %), whilst poisoning with traditional medicine resulted in a high mortality of 15.2 % and accounted for 51.7% of all deaths, always accidental". Furthermore, "Vomiting, diarrhoea, and abdominal pains were the most frequently encountered symptoms, while lungs, liver and central nervous system were commonly affected. The traditional healer was the main source, 83.4 %, while 11.3 % was bought from African medicine shops. Questioning patients and traditional healers facilitated the identification of a number of etiological agents". (Venter C, Joubert P, "Aspects of poisoning with traditional medicines in southern Africa". Biomed Environ Sci 1988 Dec;1(4))

The main paper referenced in the above-mentioned textbook is Prof. Joubert's "Poisoning admissions of black South Africans" (Joubert P, J Toxicol Clin Toxicol 1990; 28(1)), also dealing with acute poisoning admissions to Ga-Rankuwa Hospital, 1981-1985. This study determined that "Overall, the major causes of mortality were traditional medicines, responsible for 51.7 % of the deaths that occurred, followed by pesticides (23%). Of the patients who died, 62 % were poisoning by traditional medicines of which none were deliberate self-poisoning". Joubert concluded: "the main issues were the extremely high mortality" and "prevention of poisoning by traditional medicines merits high priority in the health care of the indigenous population of South Africa". Are labelled, finished, "marketed" medicines to blame here? Absolutely not.

"The ‘traditional healer’ was the main source, 83.4 %, while 11.3 % was bought from African medicine shops. In only 0.6% of cases were medicines collected by the patients themselves and in 4.4% the substances were obtained from other sources. The traditional healer is an integral part of African culture and many South Africans make use of traditional African medicines, mostly of plant origin, but also minerals or animal. In most instances these medicines are "crude watery extracts". Most towns and cities have "African medicine shops" where traditional medicines can be bought over the counter. There is currently no legislation controlling traditional African medicines. The traditional African medicine mortality is extremely high. If poisoning due to these substances can be eliminated, the overall mortality will decrease by about 50%". Most frequently implicated were Jatropha curcas, Ricinus communis and Datura strammoniun. (Joubert, J Tox Clin Tox 1990;28(1))

This study described "traditional medicines" as "a particularly important and interesting aspect of the local poisoning pattern" and pointed out that "the major cause of fatal poisoning pattern at Ga-Rankuwa appears to be very similar to that reported from Bloemfontein", and also "is similar to mortality reported from Zimbabwe" (ref above) & (Nyazema NZ, Trans R Soc Trop Med Hyg 1986;80) & (Chitsike I, Cent Afr J Med 1994 Nov;40(11)) Researchers at the University of Zimbabwe have reported that "poisoning by traditional medicines are the biggest single group of all cases." (Kasilo O, Nhachi C, S Afr Med J 1992 Sep;82(3)); "The main agents associated with acute poisoning were traditional medicines." (Nhachi C, Kasilo O, J Appl Toxicol 1992 Dec;12(6); and "Zimbabwe has a big poisoning problem, especially with regard to treatments recommended by the traditional healer." The conclusion:"Education and information dissemination on toxic agents are vital and much remains to be done. The report confirms the importance of toxicology information to the Southern African (SADCC) region as a whole". (Kasilo O, Froese E, A 10-year review of the Teaching Hospital-Based National Drug and Toxicology Information Service. Clin Pharm Ther 1989 Oct; 14(5))

Further vindicating Prof. Joubert's concerns, in spite of attempted down-playing propaganda, are the summary conclusions of Joubert's current successor, Dr. E Osuch, who extended his work as a thesis covering the subsequent period 1987-1992. Dr Osuch concluded that "Traditional medicine ingestion was responsible for more than half of all acute poisoning deaths." Also of interest is that "Eight remedies have been identified which were associated with haematuria and renal failure. One of the most common causes of acute poisoning admission to the Ga-Rankua hospital was ingestion of the watery extract of Urginea sanguinea." Even more recently Osuch et al stated: "A large percentage of acute poisonings in black South Africans is due to traditional medicines." (Foukardis G, Munting G, Osuch E, Toxicological aspects of some traditional medicines used by patients admitted to Ga-Rankuwa Hospital. J Ethnopharmacol 1994 Feb;41(3)); "Used as a blood purifier, clinical symptoms affect the, gastro-intestinal & urinary tract, central nervous system, or the splanchnic system." (Foukaridis G, Osuch E, Mathibe L, Tsipa P, J Ethnopharmacol 1995 Dec; 49(2))

Du Plooy confirms our position by clinically summarising the work of Joubert, Brand, Osuch and Foukaridis: "A solid is less harmful. Extractions are more harmful. It could be life saving if the material is identified, which may take too long. Clinically, longer than 6-24 hours after poisoning is too long. (Activated charcoal must be given within 1-hour of ingestion.) Typical clinical features include kidney failure (haemolytic anaemia), heart failure, arrhythmia and a variety of infections. In children the most common problem is dehydration and eventual kidney failure. The incidence of poisoning is high in patients who are old and go for blood purification; patients with fertility problems (male and female); for abortion; and for male STDs". ("Analysing the Epidemiology of Traditional Medicine Poisoning", Compl Health Care Summit. 25 Aug 1998)

We have also identified and independently profiled what is probably the major traditional African medicine "killer plant", again from a lead originating from Joubert, namely Callilepsis laureola, known as Impila, which ironically means "health" in Zulu. (Hutchings A, Terblanche S. S Afr Med J 1998;75.); "Toxic plants are used for medicinal purposes by the Zulu population." (Foukardis G, Joubert P, Forte M, Clin Toxicol 1992;30); "With approximately 50% of the population using Impila in Natal, it is the second most widely used and has been reported on extensively."(Ellis M. Medicinal Plant Use-A Survey, Veld and Flora 1986 Sept), eg:

IMPILA: Byrant A, Zulu Medicine and Medicine Men, Centaur, 1966 – "without doubt a virulent poison"; · Seedat Y, Hitchcock P, S Afr Med J Jul 31;45(30) – "acute renal failure"; · Wainwright J, Schonland M, Candy H, S Afr J Med 1977 Aug 13;52(8) – "found to cause fatal liver necrosis, widely used as a herbal medicine, nephrotoxic, hypoglycaemic, hepatoxic"; · Watson A, Coovadia H, Bhoola K, S Afr Med J 1979 Feb 24;55(8) – "administration of Impila is common, the practice can and does cause poisoning, hepatic and renal tubular necrosis, hypoglycaemia, alteration of consciousness, hepatic and renal dysfunction"; · Veale D, S Afr Pharm J 1987;(54) – "rootstock is toxic and can be fatal if ingested in small quantities; confusion, vomiting, diarrhoea, convulsions, hypoglycaemia and liver and kidney failure"; · Savage A, Hutchings A, "Poisoned by herbs". Br Med J 1987;295 – "clinical symptoms of Impila intoxication are abdominal pain, jaundice, hypoglycaemia, disturbed hepatic and renal function"; · Dehrmann F et al, J Ethnopharmacol 1991 Sep; 34(2-3) – "used extensively as a medicament, nephrotoxic"; · Bye S, Dutton M, In: Oliver J, ed. Forensic Toxicology. Scottish Academic Press,1992 – "hepatoxic, nephrotoxic, hypoglycaemic".

What would the relative risk/benefit ratios be for Impila? (which would have to be comparatively higher for the latter than for the former for such a toxic drug to be tolerated by any self-respecting regulatory authority) Since there are no approved uses, we have to assess the popular uses against the above-mentioned risks, and clearly this plant would never be acceptable for and on the basis of these: a) "Roots are taken as tonics by young girls in the early stages of menstruation." (Doke C, Vilakazi B, Zulu-English Dictionary, 2^nd edn. Witwatersrand Univ Press 1972); b) "Ground roots taken for snakebite and administered as enemas and in baths to protect the children of parents who have already lost many children." (Valley Trust [HST W ], pers comm Hutchings); c) "Roots also used as protective charms placed under the pillow to stop bad dreams." (Cunningham 2669 NU, in Hutchings A, et al, Zulu Medicinal Plants: An Inventory. Univ Natal Press 1996)

Even more dangerous is Impila’s traditional use during pregnancy and childbirth, likely the biggest killer of all, eg: "Roots are sometimes an ingredient in "inembe", taken regularly during pregnancy to ensure an easy childbirth, and to make an infusion for fertility." (Gerstner J , Bantu Stud 15 (3) (4), 1941); "They are sometimes included in medicines known as "isihlambezo", which are used by traditional birth attendants to ensure the health of both mother and baby during pregnancy." (Gumede M, Traditional Healers, Skotaville Publishers 1990); Dr Mike Stewart, Dept Chemical Pathology, SAIMR, has focused on Impila, yet his annual budget for all his analytical work is a mere R50,000 with not a cent from the MRC¨ (Pers comm, 31 Mar 99).

"Many black South African women use traditional African herbal remedies as antenatal medications or to induce or augment labour. Very little is known about the pharmacology and potential toxicity of plants used in these herbal remedies. Several of these plants are poisonous." (Veale, et al, J Ethnopharmacol 1992 Jun; 36(3)); "Some of the herbs are toxic in large doses. According to Joy Veale, a lecturer in pharmacology at the University of Witwatersrand, there are about 36 plants in South Africa used to induce labour, of which 15 are toxic." (Pantanowitz D, Alternative Medicine: A Doctor’s, Perspective. Southern Book Publishers, 1994) "African traditional herbal medication is commonly used in pregnancy by women attending King Edward VIII Hospital, Durban. Its use may lead to fetal distress effecting pregnancy outcome." (Mabina M, Pitsoe S, Moodley J [MRC¨ , Univ Natal, Dept Obstetrics and Gynaecology] S Afr Med J 1997; 87(8)); "Though some evidence exists suggesting negative effects of its ingestion, the maternal-fetal health impact and toxicity of isihlambezo have not been adequately studied. Pharmacological analysis suggested both therapeutic and harmful consequences of isihlambezo." (Varga C, Veale D, Soc Sci Med, 1997 Apr, 44(7))

Paediatric use is also seriously problematic. (Bodenstein J, S Afr Med J 1977 Nov 5;5;52(20)); More specifically eg at Habisa Hospital, Kwazulu Natal: "We have observed a distinct clinical syndrome amongst acutely unwell children frequently associated with the administration of a traditional medicine enema. Admission was frequently prompted by sudden, marked clinical deterioration following enema administration (68% within 24 h). Clinico-pathological features of this enema syndrome:- respiratory distress/insufficiency with tachypnoea, abdominal distension, hypotonia and loss of consciousness occurred frequently. In-hospital mortality was 28% and higher in those receiving herbal (43%) rather than chemical (21%) enemas. Hyperkalaemia, leucocytosis (> 15,000 mm3) and respiratory distress/insufficiency occurred more frequently in those who died." (Moore D, Moore N, Ann Trop Paediatr, 1998 Jun, 18(2)); Pediatric enemata are a problem in other provinces, eg: "herbal intoxication regularly occurs, with high mortality in infants, especially under 1 year of age." (pers comm, Dr Baker, ICU, Livingstone Hospital, PE, 26 Mar 1999)

Besides the above-mentioned subsets, the following represent further confirmation of this enormous problem. "In the treatment of measles, a variety of indigenous medications are used, some of which are potentially dangerous." (Ijsselmuiden C, S Afr Med J 1983 Mar 5;63(10)); "Although widely recognised by physicians, the acute renal failure resulting from the use of herbal preparations obtained from witch-doctors has not been fully described." (Gold C. Clin Nephrol 1980 Sep;14(3)); "In cancer of the oesophagus, traditional medicines are a significant risk factor." (Sammon A, Cancer 1992 Feb 15;69(4)) "The potent effects of their herbal medicines can result in damage to any part of the gastro-intestinal tract, and may be fatal. Diseases caused by witch-doctors constitute an important facet of the disease spectrum of blacks." (Segal I, Tim L, S Afr Med J 1979 Aug 25;56(8)); "The inappropriate use of traditional medicines results in numerous fatalities, invariably in children." (Bye S, Dutton M, J Ethnopharmacol 1991 Sep; 34(2-3))

"Traditional medicines can be beneficial, dangerous or useless in a pharmacological or psychological capacity, their dangers being mainly as direct irritants or as hepatic or renal toxins. Mild to moderate toxicity from short or long term use is difficult to separate from the original illness. Greater absorption from enemas coupled with irritant proctitis and perforation indicate that enemata have a high mortality". (Ellis G, Medicinal Plant Use, Veld & Flora, Sept 1986) "Traditional medicines (or mutis) are usually administered orally or as an enema by a traditional healer . Gastro-intestinal irritation was the most common syndrome (54%) experienced after traditional medicine administration. Cardiac glycosides are often found (44%) in autopsies [Jhb Forensic Chem Lab] where death was presumed to be caused by herbal medicine. It is concluded that in patients with gastro-intestinal symptoms, traditional medicine cardiac glycosides should be suspected." (Mc Vann A, Havlik I, Joubert P, Monteagudo F, S Afr Med J 1992 Feb 1;81(3))

"Herbal medicine may be directly responsible for harmful or fatal results, and frequently cause especially gastro-intestinal disorders, which may certainly be ascribed to the witch-doctor and his medication." (Van Rensburg H, Mans A, Profiles of Disease and Health Care in South Africa, Academica 1982); Dr Desmond Pantanowitz, Professor of Surgery, University of Witwatersrand writes: "Many dangerous substances have been isolated from nyanga concoctions, including the orange crystals of potassium dichromate, which can cause liver failure. Cantharides (Spanish fly) is often used to treat impotence; the side-effects of this poison are irritation of the gut and urethral mucosa, as well as kidney failure. Some nyangas even add battery acid to their concoctions to give them some ‘body’. The concoctions are administered via various routes: oral, anal, and through the skin. Damage may occur along the entire gut, from the oesophagus all the way through to the anus. Ritual enemas are a favourite method used. Infants receive up to 100 enemas before age two. Enemas may be prescribed for ritual purposes and for the treatment of complaints as diverse as impotence, dysmenorrhoea, fever, diarrhoea, constipation, abdominal pain and headache. The traditional healer can be a danger to society". (Pantanowitz D, Alternative Medicine: A Doctor’s Perspective. Southern Book Publ 1994)

"In the rural setting, a truncated cow horn is often used to dispense the enema; this may mechanically damage the rectum, causing anorectal laceration or rectal perforation. Complications are seen regularly at academic hospitals, particularly Baragwanath. Conditions that are repeatedly diagnosed are gut necrosis with perforation, peritonitis, gram negative endotoxic shock, disseminated intravascular coagulation, adult respiratory distress syndrone and hepatorenal failure, which can all result in the death of the patient. While the rural individual is given mainly herbal enemas, such as the poisonous milkweed species Aesclepsias physocarpa, the sophisticated urban dweller is given additional exotics such as Dettol, vinegar, copper sulphate, potassium permanganate, hydrochloric acid, sodium hydroxide, and the favourite, battery acid. To my knowledge patient’s families have never charged murder against a traditional healer in this country. No evidence can be obtained in a court of law. There is a code of secrecy and silence governed by a fear of retribution." (Pantanowitz D, Alternative Medicine: A Doctor’s, Perspective. Southern Book Publishers, 1994)

Besides poisonous plants, other toxic agents controversially used by traditional healers are: battery acid, chloroxylenol, potassium permanganate / dichromate, and copper sulfate. (Ellenhorn's Medical Toxicity: Diagnosis and Treatment of Human Poisoning, Williams & Wilkins, 2^nd Edn.1997). "Renal failure may occur with potassium dichromate". (Wood et al, S Afr Med J, 1990 Jun 16;77(12), (Michie et al, Hum Exp Toxicol, 1991;10) Potassium dichromate is used primarily for its colouring rather than disinfection action. (Bye S, Dutton M. Proc Int Assoc Forensic Toxicol, Scottish Academic Press, 1992); Du Plooy: neon colourants. (Analysing the Epidemiology of Traditional Medicine Poisoning, Compl Health Care Summit. 25 Aug 1998)

Dr Steven Toovey, Director of Medinfo, says: "We know, from experience, that some traditional medicines are toxic". The reporter continues: "Dr Toovey ran independent tests in two laboratories on a traditional mud remedy to "strengthen the blood, eaten mainly by pregnant women with anaemia. Both laboratories found arsenic and mercury in the samples. Among the test tubes filled with indigenous roots and herbs at Groote Schuur Hospital’s department of pharmacology (Folb-Ed), researchers have encountered problems that move beyond the diseases and ailments they set out to cure. Toxic chemicals in muti remedies have raised alarm in the scientific community." The photo caption: "TRADITIONAL WEAPON: a researcher (African-Ed.) runs a test on local muti" (Emily Osinoff, " Indigenous plants could provide real muti", Sunday Argus, May 30 1999)

We have mentioned the openly identified poisonous species implicated in the Ga-Rankuwa sub-sets, but these are only 5 out of 24, and neither du Plooy, as custodian of Joubert, Brand, and Osuch’s Medunsaf toxicological data, nor Folb, as custodian of the UCT TramedF data, have complied with our repeated requests for information access to compile and release an urgent educational African botanical toxics list.

PHARMAPACT are singly campaigning for the necessary reform, via this and earlier efforts. We are trying to prepare an urgent toxics short-list, but are not receiving any co-operation from the authorities nor the data custodians in this regard. PHARMAPACT will refrain from publishing a compromise list, insisting on rightful access to the Tramed database, which was again denied us on 24 May 1999 by professor Folb, claiming that this aspect still had to be developed, yet declined our offer to undertake this work. (Pers comm, T/Dr A Rees)

In the meantime, besides this document, the following remain the only detailed but very limited sources of such information, but none in a form readily accessible or meaningful to the traditional healer / medicine fraternity: a) Watt J, Breyer-Brandwijk M, The Medicinal and Poisonous Plants of Southern and Eastern Africa, 2^nd Edition, E & S Livingstone Ltd, 1962; b) Hutchings A, Zulu Medicinal Plants, Univ of Natal Press, 1996. It is interesting to note that Watt, like Folb, was a Professor of Pharmacology (Univ of Witwatersrand), but unlike the latter, cared enough about the African people to use the institution at his disposal to laboriously collate the existing toxicological information and make it widely available, including to all hospitals for the treatment of herbal poisonings. On the other hand, Folb, leader of the Traditional Medicines ProgrammeF and handed public custodianship of an electronic database 20 years under development, cannot 5 years later provide a toxics list, nor is he willing to grant access to those volunteering to undertake this priority work. Folb, as Chair of the MCC for 18 years, had a mandate to ensure the protection of the public from toxic medicines, yet instead of using the database to identify and alert healers to the risks, only lucrative new drug leads were sought. We will press charges of genocide, and complicity thereto against all perpetuating officials.

None of the above-mentioned identified toxics are at all covered in the South African Traditional Healer’s Primary Health Care Handbook, based on the TramedF database and produced by the Medical Research Council and the Traditional Medicines Research Group (TMRG)ª of the Universities of Cape Town and of the Western Cape. Prof Eagles, Head of the Pharmacy School, UWC, as one of three tiers of the TMRG and who was and is again the vice Chairperson of the MCCY /MRA, is also, with du Plooy, an influential member of the Traditional Medicines Working Group, National Reference Centre (NRC)§ .

Shockingly little or nothing has been done about this unacceptable situation, least of all by those who over the period that this information has been directly available to them and who have been directing MCCy policy under the shallow guise, repeated ad nauseam, of being the custodians of public safety from toxic medicines and insisting that they have been empowered to control all substances matching the enacted definition of a medicine. The previous, transitional and new authority bear legal responsibility.

Instead of using the 60,000 entry TRAMEDF database available to the WHOCCDP to "monitor all adverse reactions to medicines in South Africa, investigate national problems of drug toxicity, recommend policy in this regard and encourage the rational and safe use of medicines, including traditional medicines, to address an important and comparatively neglected scientific research and public health field, and to establish the rational and safe use of traditional medicines", the facilities are "presently engaged in large amounts of research based upon the extraction and isolation of active compounds from plants used by traditional healers in the treatment of disease." (Homepage:University of Cape Town, Dept of Pharmacology)

Ethnopiracy projects at TramedF include: "Natalie Brine – anti-malarial compounds from plants; Sandra de Klerk anti-malarial activity present in plant mixtures used by traditional healers; Motalepula Gilbert Matsabisa – ethno-pharmacology in drug development; investigation of the anti-malarial activity of indigenous Southern African plants; Siyabulela Calvin Ntutela – efficacy of plants used in traditional treatment of tuberculosis; Portia Rachaka - potentiation of immune response by traditional herbal remedies (Homepage: University of Cape Town, Dept of Pharmacology); also "Malaria is the focus of research UCT’s Pharmacology Department, where Dr Pete Smith has examined plants used by traditional healers for treating fever." (Diana Streak, Fair Lady, Sept 1995); Matsabisa is testing plants discovered by traditional healers in KwaZulu–Natal in treating malaria." (Sunday Times, 21 March 1991); More recently:"the Traditional Medicines Research Group at UCT sent a Masters student to a hi-tech laboratory in Barcelona that can analyse plant material much faster than in SA. One was obtained from the Durban herb market and the other is widely used throughout South Africa." (Claire Bisseker, Financial Mail, 19 Mar 1999); "Dr Karen Barnes, a clinical pharmacologist (?) supervised clinical trials of the drug in a high-risk area in KZN. Sibongile Pefile’s area of research involves the use of plants to treat viral skin disorders." Laurice Taitz, Sunday Times, 2 May 1999)

The Traditional Medicines Project (Tramed)F is based on a database donated by Noristan Laboratories to the University of Cape Town’s Pharmacology Department to be incorporated into a national database to which all interested parties can have access. (Lindy Hughson, editor, Pharmaceutical and Cosmetic Review, July/August 1995); The project has since 1995 been assisted by Dr T Felhaber, supported by a Fellowship from SA Druggists, and since 1991, Isaac Mayeng, supported by a grant from the Medical Research Council (MRC)¨ . Mayeng is now employed full-time as senior medicines control officer with the MCCY /MRA, in serious vested interest conflict with his commercial ventures. This project had its genesis at a the 28^th Annual Congress of the South African Pharmacology Society on the 24 September, 1994, at which most of the ethnopirates mentioned here were present. (Nigel Gericke, Tramed, Indigenous Plant Use Newsletter, November, 1994); Noristan Laboratories, who originally donated the database to UCT have subsequently been acquired by Hoechst, giving the global drugs cartel right of access to the vastly expanded database.

The database has had added, a substantial collection of information on traditional medicine donated by the Hans Snyckers Institute of the Medical School, Univ Pretoria. Further collaboration exists with Dr Anne Hutchings (ex-Univ Zululand), Prof Wimpie du Plooy’s Dept of Pharmacology at Medunsaf , Dr Carl Albrecht at the Dept of Pharmacology and Dr Michael Becker at the Dept of Virology, both at the Medical School, Univ Stellenbosch. Dr David Gammon, Dept of Chemistry, UCT, is "collaborating with the Dept of Pharmacology in the investigation of the biological activity of medicinal plants found in the southern African region, identified through traditional medicine." (UCT Dept of Chemistry homepage) Central to the TramedF programme from an early stage has been T/Drs Solomon Mahlaba and Isaac Mayeng. Both are major sell-outs, benefiting only themselves, as the ancestral knowledge of the nation is raped by commercial interests, whilst scientific feedback to the traditional healers as a whole has been negligible. As reward, both have enjoyed virtually proprietary access to the database for their own medicines businesses.

Nigel Gericke, a medical practitioner, a member of the CMC, and the founder of TRAMEDF whilst working as phytomedicines development manager for SA Druggists, states in his CV that he continues to serve as consultant to TRAMED, including "ongoing research into side-effects" and "to encourage the safe use of indigenous medicinal plants, and the development of a database, including toxicology." In late 1995, at the request of Folb, as the MCCY , a study and recommendations were made by Gericke for the development of a South African approach, yet ironically no urgent regulatory action is being imposed on this sector, which by far represents the major, if not sole risk to public safety from natural health substances against which the MCCY /MRA claim to act when witch-hunting the international natural health substance traditions.

Dr. Gericke in the meantime developed his own commercial range of ethnopirated indigenous medicines (Healer's Choice brand) and with his senior at SAD, Bosch van Oudtshoorn, co-authored a recent book (Medicinal Plants of South Africa, Briza, 1997), (to "independently" promote their products?) developed from the TRAMEDF database, to which it gives no acknowledgement, nor to the traditional healers. Most irresponsibly this book does not even begin to address the above-mentioned vast toxicological problem, since for the majority of the 132 plants featured, in spite of significant toxicities, (besides the obligatory publisher’s indemnity) the book treats these as if they did not exist, except for occasionally mentioning that this or that isolate has toxicological potential, but largely from a commercial perspective.

A shockingly similar situation inexplicably exists with the recently published South African Traditional Healer's Primary Healthcare Handbook (UCT, 1997), also a product of the TRAMEDF Project, which, although it provides short token precautionaries for those toxics among the 55 plants featured, simply does not do justice in addressing the enormous problem of acute poisonings and fatalities arising from traditional African medicines. We have to question and protest the deliberate exclusion of an educational Toxics List, especially considering Folb’s above-mentioned statements regarding toxicity, and more recently, those of Eagles: "In favour of muti is that the cost is lower than that of allopathic medicines. Against it stands the risk of poisons, toxicity, counterfeits and chemical pollutants. If people aren’t enlightened about the dangers of mixing a handful of leaves together, the results can be uncontrollable". (Lee P, undated, Independent Online)

Some 3000 plants are in use, 10 % in major use, and of which the most toxic or those responsible for most of the serious poisonings and fatalities are not even featured or identified in these two publications, especially curious considering that they both have their genesis from within TRAMEDF , and against the claimed public safety interest, much of which is hypocritically regurgitated by Folb in the first paragraph of his forward to the manual. The authorities have no excuse to plead ignorance in defence of their callous inaction in the face of so much innocent human suffering and loss of life, since this is the primary responsibility of the Medicines Control Council, and the traditional African healers and sellers of herbal medicine are not directly to blame. The MCCy /MRA / DOH upper hierarchy bear legal responsibility, prior to and hereafter for every one of the many thousands of preventable deaths occurring from traditional medicine poisonings every year. This author will not rest until these problems are addressed.

In addition to TRAMEDF , is a Traditional Medicines Research Group (TMRG)ª which is a broader joint venture between the Medical Research Council, the Department of Pharmacology at UCT and the School of Pharmacy of the University of the Western Cape, which is also engaged in ethnopiracy testing of plant extracts at UCT, according to Dan Ncayiyana, Deputy Chancellor of UCT: "to isolate active compounds to develop new drugs." (Electronic Mail & Guardian, 19 Oct 1997); "The University of the Western Cape is testing plants for anti-tuberculosis properties". Dr Leng, chairperson of the Department of Pharmaceutical Chemistry says "The plants we have selected for screening are ones already used by traditional healers." (Diana Streak, Back to our roots, Fair Lady, Sept 1995); It is no surprise that the person who was preferred by the MCCY to take over as Chairman in June 1998 was vice chairman, Professor P. Eagles, head of the UWC School of Pharmacy, who is currently expanding on Folb's ethnopiracy operation, and has taken over his role as a major influence (vice chair) on the Council. Eagles is also the influential chairperson of the NRC§ .

"Traditional healers seek recognition and scientific verification of their remedies. We want to gain their trust. What we will not do is use their intellectual property to make profits which do not benefit them An important objective will be to create a comprehensive traditional medicines database for use by traditional healers, policy makers, drug regulatory authorities, the pharmaceutical industry and the public." (See the lie!) "We are committed to making the database universally accessible." (MRC Press Release, 6 February 1997) Both the author, as a representative of the Western Cape Traditional Healers and Herbalists Association, and his research associate, T Dr Anthony Rees, as chairman of the South African Herbalists Association, and PHARMAPACT have been denied access to the database. Dr Phillip Kubukeli, President of the Western Cape Traditional Healers and Herbalists Association is recorded on a televised documentary (SABC, Options, 1998), as having never had access to the TramedF database to which he and his colleagues have so freely contributed. Why? Kubukeli has naively been collaborating with TramedF for years, handing over indigenous knowledge for an occasional hand-out and in the hope of recognition for the healer’s work. Kubukeli has stated that he "support(s) the idea of published research, since some herbs can be a hazard, so researching them will make us more sure that our medicine is safe, and our medicine will be acknowledged by the government, but fear(s) that by exposing too much, healers will be made redundant." (Diana Streak, Back to our roots, Fair Lady, Sept 1995); Sadly the Tramed collaboration has contributed more to the latter aspect, yet the naivety persists: "In my collaboration, we are working closely with Pharmacology departments in the study of the safety of our traditional medicines." (Presentation to PHARMAPACT’s Health Freedom SA Indaba, Knysna, June 1998)

It is not possible to reconcile the false promotional rhetoric with the unequivocal facts: Professor Eagles: "Our brief (National Drug Policy) was to investigate traditional medicines for toxicity, efficacy, safety and quality to incorporate them in the health care system, and be able to register and control them." It is quite clear that the MCC (TramedF via Folb, and now Eagles) and in particular in their "brief to establish a Complementary Medicines Committee (CMC), including all experts" for the aforementioned purpose have not succeeded, not in spite of, but because of the domination on this committee by the likes of Gericke, Mayeng and Mahlaba. Neither Mayeng, nor Mahlaba have true representative mandate by the majority of traditional healers, nor should they, because of their obvious financial vested interests be qualified for any policy or decision-making process, yet nevertheless both hold influential positions on the Traditional African Medicines Committee of the CMC and the Traditional Medicines Working Group of the National Reference Centre (NRC)§ , Dept of Health. Mayeng furthermore, since late 1998, is Senior Medicines Control Officer, Medicines Registration, and heads the transitional Complementary Medicines Section at MCCy /MRA.

T/Dr Solomon Mahlaba manufactures and markets his own extensive range of "finished, labelled and marketed" traditional African medicines, branded "UMUTI AMANDLA", which is known to the MCCy , this matter and that of traditional medicines manufactured by "Guideline Products" having been brought to the attention of the Registrar, Precious Matsoso and the Inspectorate. T/Dr Isaac Mayeng, in a recent book confirms his vested interest as follows: "I also have my own private herbal medicines production and supply business." Proof of his two-facedness is in his own words: "Some healers think that if they cooperate with the medicinal side, the government will pay them a salary. Well that can never happen. There needs to be (bank?) checks (cheques?) and balances. At the national level, the element of power and greed comes into play quickly." (Susan Schuster Campbell, "Called to Heal", Zebra Press, 1998)

Hypocritically in February 1998, Mayeng advised the Parliamentary Portfolio Committee on Health that "traditional medicine had to be regulated to ensure standardisation of herbal medicine, a code of conduct and ethics, the passing on of invaluable knowledge, and patenting" (Vuyo Mvoko, News, Business Day, 19 February, 1998), and in February 1999, Mayeng presented the fruits of this stolen heritage, the "TramedF Monographs" to the WHO in Geneva for the rest of the pharma-world to plunder, while South African consumer’s are poisoned to death in their thousands for lack of toxicological information. Mayeng now heads the section of the MCCy /MRA which aims to engage in both this and all the preceding activities he so hypocritically warned readers about in the preceding interview. (Susan Schuster Campbell, 1998); Mayeng was recently exposed as a fraud, when in response to a query whether the ICCÆ had been informed of the pending 26 February meeting, he claimed that the traditional healer’s were not interested, and that he had no contacts for them (a lie), only to pretend the next day to be taking the initiative in informing the ICCÆ of a critical meeting.

This did not satisfy Sipho Mndaweni, president of the Interim Co-ordinating Committee of Traditional Practitioners in South Africa (ICC)Æ who complained that "traditional healers and vendors may end up being squeezed out of the market" and who insisted that "South African Druggists is just testing the water before marketing more traditional medicines to be sold over the counter". Mndaweni says, "We won't see a cent of the vast profits they will make, even though people will buy these goods thinking it's the same as what we do." His committee has made submissions to Parliament for "some control over the trademark 'traditional medicines' and to stop this kind of abuse." (Angella Johnson, "Inyanga rage as drug groups muscle in!" Electronic Mail&Guardian, May 11, 1998); PHARMAPACT are in strategic alliance with the ICCÆ , monitoring, recording and reporting developments to our best ability with the documentation at our disposal.

Worst of all is that this ethnopiracy is happening in our own back yard, with State support via the Dept of Health and Medical Research Council¨ . Witness the following report-back from one of these meetings and then an example of the rape of the traditional African medicine heritage by a consortium of most of the above-mentioned names and institutions, spearheaded by the statutory Council for Scientific and Industrial Research (CSIR)Ä , headed by Dr M Horak, team-leader of the Database Working Group of the Traditional Medicine Working Group of the NRC§ , with the full co-operation of Eagles, Matsoso, Makhambene, de Wet and Mayeng, all of the MCCy , Walters of the MRC¨ , Bannenberg and Peteni of the DoH, and du Plooy of Medunsaf , plus Mahlaba and others. Nothing is being done about the tens of thousands of fatal poisonings and untold morbidities, fearing non-co-operation by healers on the "claims for cures" scam.

At the first meeting it was decided that "Different rules and regulations would apply or be needed to address differences in the supply of traditional medicines to patients. 1) Traditional medicines commercially available (manufactured, and packaged to be sold in retail outlets); 2) Traditional medicines prepared by a healer for a specific patient on an individual name basis." At the next meeting, "the involvement of the MCCy centred on claims of a cure for some conditions. The moment a plant is claimed to cure a disease it can be legislated as a medicine. Current definitions of safety and efficacy will be revisited. Safety and some efficacy have partially been addressed by the fact that it has been given to patients for years. The major difference is between the individual use of a product and the bulk distribution and sale thereof. Safety needs to be addressed if a product is sold in bulk." (NRC§ 4 June 1997); "The MCCy is concerned with medicines of plant origin being pre-packed and sold in shops and not with one-on-one treatment of a patient. It also concerns the issue of herbs being sold on the pavement in certain cities." (NRC§ 11 Sept 1997)

REPORT-BACK REGARDING THE LEGAL ISSUES WORKING GROUP OF THE NATIONAL REFERENCE CENTRE § FOR TRADITIONAL MEDICINES, NATIONAL DRUGS POLICY,

(This report was prepared for PHARMAPACT, the Interim Co-ordinating Committee of Traditional Medical Practitioners of South Africa (ICC)Æ , and the Western Cape Traditional Healers and Herbalists Association)

The NRC§ for Traditional Medicines is a facilitating initiative of the Department of Health, arising out of the National Drug Policy for South Africa. The stated aim is to "investigate the use of effective and safe traditional medicines at primary level." As per the WHO, "traditional medicines will be investigated for efficacy, safety and quality with a view to incorporate their use in the health care system". Quite clearly, the traditional healers are not central to the plan in the long term, only their medicines are of real interest. Most revealing of all is the unequivocal statement that "Marketed medicines will be registered and controlled". A further insight is obtained from the outline of the functions of the reference centre which these working group meetings are busy establishing and which will include: "development of a national database of indigenous plants screened for efficacy and toxicity; testing for efficacy and toxicity."

Who exactly is running the show? Certainly not the traditional healers, though there are a fair share of non-representative opportunists and naïve stooges providing the obligatory window dressing, including in this instance: T/Drs. Simon Mhlaba (Natal Nyanga's Assoc.), Seth Seroka (African National Healer's Assoc.), and Isaac Mayeng (Tramso - Trad Med Syst Org), Prof. Folb's stooge as strategic liaison person for the traditional healers. Significantly all are on the equally non-representative and non-democratic African Traditional Medicine Sub-Committee of the Complementary Medicines Committee of the MCCy . This concentration of influence on both forums illustrates either the deliberate selective nature of the canvassing for participants, or lack of support by the majority. There are otherwise only a handful of collaborating traditional healer opportunists, all in all, in about 20% minority to the academics and others.

Having lined-up the window dressing, the reminder of non-traditional healer Europeans at the meeting ensured that the group-leader would be Dr. Nico Walters of the Medical Research Council¨ , Cape Town (speciality: indigenous technology), who acknowledged to me prior to the meeting that he was part of Professor Folb's team (and one of the tiers in the Traditional Medicines Research Group (TMRG)ª , including Folb's UCT Pharmacology Dept. and Prof. Eagles UWC Pharmacy Dept.). The MRC¨ are closely involved with the WHO Collaborating Centres for Drug Policy and actively support the ethnopiracy operations of Professors Folb, Eagles and du Plooy by way of financial grants. The MRC¨ pride the TMRGª with "using modern scientific and biomedical knowledge to investigate medicinal plant extracts and to isolate boiactive compounds for developing safer and more effective drugs".

Also prominently involved was the Council for Scientific and Industrial Research's (CSIR) Ä Dr. R. Marthinus Horak, who quite frustrated, informatively pointedly reminded all that "the focus was not intended to be traditional healers, but rather traditional medicines". Dr. Horak is the Manager of the Chemical and Microbial Products (CMP) Programme of Foodtek at the CSIR Ä . "The CMP Programme (in their own words) recently launched a major bioprospecting project that is aimed at investigating most of the 23,000 South African indigenous plants for pharmaceutically active compounds, which plant extracts are to be tested by the by the CMP Programme." (Bulletin of the Pl. Pr. Res. Inst. Autumn1998).

Also from the minutes of the Traditional Medicines Working Group is a direct reference to vested interests: "The centre will not only encompass the MCCY but other organisations like the CSIR Ä and MRC¨ will be included as partners. The CSIR Ä is currently in a consortium with other institutes, busy with "bioprospecting". In 10 years the group wants to scrutinise 80% of indigenous medicinal plants. There was a concern that the CSIR Ä has a financial interest and could take over the market. The CSIR is a national research institute, owned by the government and is as such not profit orientated." (NRC 11 September, 1997)

Let us now briefly investigate this totally fraudulent concept and claim of "non-profit bioprospecting": The CSIRÄ ’s Bioprospecting project aims to "investigate most of SA’s indigenous plants for commercially valuable properties. We will strive to add value to indigenous knowledge through scientific investigation of eg traditional medicines derived from plants, in close collaboration with traditional healers, legal advisors and policy-makers, to develop equitable collaboration, subject to agreements which define confidentiality, intellectual property rights and reciprocity". Please bear in mind that traditional ancestral knowledge belongs to no one individual or group of individuals, but to whole communities! To claim such information for oneself and sell it is clearly theft and fraud and should be punishable by both civil and traditional court. Legitimately only a unanimous community can make such a decision. Foodtek, the CSIRÄ department where the Bioprospecting project is resident, claims that "throughout this process, we will ensure the equitable sharing of benefits between all parties involved, the intellectual property of participants, in particular sharers of indigenous knowledge, is respected and safeguarded". (Foodtek Homepage 1998) Clearly however, if the true owner’s are not participants, the thief (healer) is not only paid for stolen property, but has their identity and knowledge of their crime safeguarded by the receiving accomplice (CSIRÄ ).

Claims to "take account of the rights and interests of indigenous peoples and provide partnerships which will permit communities to benefit from their indigenous knowledge" (Foodtek Homepage 1998), are clearly just false public relations rhetoric, being as they are, irreconcilable with the facts, eg: " The discovery, development, world-wide patenting and licensing of an appetite suppressant derived from an indigenous plant by Horak and his colleagues at CSIR-Foodtek gave impetus to the establishment of the Bioprospecting consortium. The product is to be commercialised as a prescription medicine. A licensing agreement for development and commercialisation has been signed between the CSIR and the UK-based company, Phytopharm. Pfizer, is funding the construction of a FDA-approved clinical supplies unit at CSIRÄ for the manufacture of P57, to be used in clinical trials". ("Bioprospecting breakthrough", Pharmaceutical & Cosmetic Review – Nov/Dec 1998)

"Under the agreement, Pfizer has acquired an exclusive world-wide licence to develop and market P57. Phytopharm will receive up to 32 million Dollars in license fees and milestone payments based upon the achievement of specific objectives. In addition, Pfizer will make at least 7 million Dollars in contributions in an early development programme to be carried out by Phytopharm, who will also receive royalties on sales of P57 by Pfizer. Financial Advisors: NM Rothchilds & Sons Ltd." (Press release, Phytopharm Homepage, Aug 1998); "The company did not name the plant to protect "its" intellectual property. Financial terms of the deal with the CSIR were also not disclosed". (Cape Times, Business Times, 24 Jun 1997); "CSIRÄ scientists refused to divulge the species of the miracle indigenous plant code-named P57. American drug company Pfizer bought exclusive rights to market P57 in an estimated R 240 million deal". (A Baleta, Sunday Argus 3/4 Oct 1998); "Neither company was prepared to name the herb, which has been dubbed P57. Stuart Thomson: These companies come here, flash their money around, and for a few measly bucks, convince traditional healers to hand over ancestral knowledge." (L Taitz, "SA flower power for Viagra giant: Accusations of ‘ethno-piracy’ as Northern Cape plant is targeted for use in weight-loss drug", Sunday Times, Aug 1998)

The Bioprospecting Programme is supported by the activities of a South African based consortium, managed by CSIRÄ -Foodtek under its Chemical and Microbial Products Programme (CMP) by Dr Marthinus Horak. Consortium members currently include numerous parastatals and significantly the MRC¨ , and the universities of Cape Town (Folb), The North and Western Cape (Eagles), in collaboration with government departments and policy makers. This is clearly a case of "State genocide and ethnopiracy against the African people".

The National Drug Policy for South Africa has as it’s stated "Health Objectives: To ensure the safety, efficacy and quality of drugs; ensure good dispensing and prescribing practices; promote the rational use of drugs by prescribers, dispensers and patients through the provision of the necessary training, education and information; promote individual responsibility for health, preventive care and informed decision making. Legislation & Regulations: To ensure that drugs reaching patients are safe, effective and meet approved standards and specifications. Only drugs, which are registered in South Africa, may be imported, produced, stored, exported and sold. ‘Marketed’ traditional medicines will be investigated for safety and quality. ‘Marketed’ traditional medicines will be registered and controlled. Rational use of Drugs: To promote rational prescribing, dispensing and use of drugs by personnel and to support the informed and appropriate use of drugs by the community". (National Drug Policy for South Africa, Department of Health, January 1996)

The following are the most introductory articles of the:

Genocide is a crime under international law, contrary to the spirit and aims of the United Nations and condemned by the civilised world; At all periods of history genocide has inflicted great losses on humanity; In order to liberate mankind from such an odious scourge, international co-operation is required.

Ph / fax: 044-5327765; PO Box 2404, Knysna, 6570. E-MAIL: pharmapact@hotmail.com or gaia.research@pixie.co.za

Web-site: https://www.angelfire.com/biz/pharmapact/MAIN.html

BACK TO MAIN PAGE